Novo Nordisk | NVO - Interest Income

Stock Price
37.08
Daily Change
-0.40 -1.07%
Monthly
-21.81%
Yearly
-52.89%
Q1 Forecast
35.99

Novo Nordisk reported DKK3.42B in Interest Income for its fiscal quarter ending in March of 2025.





Interest Income Change Date
Aurora Cannabis CAD 1.85M 120K Sep/2025
Bausch Health Companies USD 15M 2M Sep/2025
Corcept Therapeutics USD 5.02M 7K Sep/2025
Drreddys Laboratories INR 796M 332M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Merck USD 96M 27M Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Novo Nordisk DKK 3.42B 2.04B Mar/2025
Pacira USD 8.53M 3.53M Sep/2025
Phibro Animal Health USD 0.08 0.09 Dec/2024
Sanofi EUR 114M 38M Sep/2025
Supernus Pharmaceuticals USD 2.28M 2.25M Sep/2025
Zoetis USD 26M 7M Sep/2025